-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Zymeworks, Raises Price Target to $39

Benzinga·09/29/2026 18:01:02
Diffusion vocale
Citigroup analyst Yigal Nochomovitz maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $38 to $39.